Gene: PDPN
Official Full Name: podoplaninprovided by HGNC
Gene Summary: This gene encodes a type-I integral membrane glycoprotein with diverse distribution in human tissues. The physiological function of this protein may be related to its mucin-type character. The homologous protein in other species has been described as a differentiation antigen and influenza-virus receptor. The specific function of this protein has not been determined but it has been proposed as a marker of lung injury. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO03294 | PDPN Knockout cell line (HEK293) | Human | PDPN | 1:3~1:6 | Negative | Online Inquiry |
PDPN Gene Knockout Cell Lines are advanced biological tools specifically engineered to facilitate the study of the podoplanin (PDPN) gene and its associated pathways. These cell lines are created using CRISPR-Cas9 technology to effectively disrupt the PDPN gene, enabling researchers to investigate the functional roles of podoplanin in various physiological and pathological contexts. By nullifying the expression of PDPN, these cell lines serve as valuable models for examining cellular behaviors, including migration, adhesion, and response to microenvironmental cues.
The primary mechanism of action for PDPN Gene Knockout Cell Lines lies in their ability to mimic the loss-of-function scenarios found in numerous studies related to cancer metastasis and lymphatic development. By observing the phenotypic and molecular alterations in PDPN knockout cells, scientists can decipher the gene's contributions to disease processes, making these cell lines indispensable in both basic research and therapeutic development.
In terms of scientific importance, PDPN Gene Knockout Cell Lines are crucial for uncovering the implications of podoplanin in tumor microenvironments, particularly its role in epithelial-to-mesenchymal transition (EMT) and immune evasion. They have applications in drug screening, biomarker discovery, and the elucidation of complex signaling networks inherent in cancer biology and tissue regeneration.
One of the key advantages of our PDPN Gene Knockout Cell Lines is the precision of the gene-editing technology utilized, ensuring consistent knockout efficiency and reproducibility in experiments. Unlike traditional methods of gene silencing, such as RNA interference, our knockout lines offer a stable and long-term solution for studying PDPN's effects across various passage numbers.
For researchers and clinicians focused on cancer research, immunology, or regenerative medicine, our PDPN Gene Knockout Cell Lines provide an unparalleled platform for innovation and discovery. Their capability to elucidate the intricate mechanisms at play in diseases where podoplanin is implicated gives users a competitive edge in their research endeavors.
With extensive expertise in genetic engineering and a commitment to advancing biological research, our company is dedicated to providing high-quality products like the PDPN Gene Knockout Cell Lines, supporting the scientific community in making groundbreaking discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.